Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
August 09, 2023 at 09:13 pm EDT
Share
From April 1, 2023 to June 30, 2023, the company has repurchased 150,000 shares, representing 0.08% for BRL 3 million. With this, the company has completed the repurchase of 1,713,200 shares, representing 0.96% for BRL 42.89 million under the buyback announced on June 14, 2022.
Blau Farmaceutica SA is a Brazil-based company engaged in the pharmaceuticals sector. The Company focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The Company operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.